SP

Sanjay Pal

Active Director Director DIN 09670698
DIN 09670698 First appointment Jul 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Sanjay Pal

Data last updated:

Sanjay Pal is a Director at Vengbo Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Vengbo Pharmaceuticals Private Limited reported revenue of ₹1.6 Lakh (FY 2023).

DIN 09670698
Primary Designation Director
Industry Chemicals
First Appointment 12 Jul 2022
Oldest Company Age 4 yrs
Largest company Vengbo Pharmaceuticals Private Limited · ₹1.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jul 20222022₹1.6 Lakh (FY 2023)Active

Board colleagues of Sanjay Pal

NameDINCompanyDesignation
Suvidha Pal09670699Vengbo Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vengbo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjay Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Pal

Sanjay Pal currently holds 1 directorship: Vengbo Pharmaceuticals Private Limited (Director, since 12 Jul 2022, revenue ₹1.6 Lakh (FY 2023)).

Sanjay Pal was first appointed on 12 Jul 2022 as Director at Vengbo Pharmaceuticals Private Limited.

The current boards of Sanjay Pal's companies include Suvidha Pal (Vengbo Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available